This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.
What Must You Know Ahead of Flowers Foods' (FLO) Q2 Earnings?
by Zacks Equity Research
Flowers Foods' (FLO) second-quarter results are likely to reflect gains from core priorities like innovation and brand building amid escalated costs.
Factors Likely to Drive Purple Innovation's (PRPL) Q2 Earnings
by Zacks Equity Research
Purple Innovation's (PRPL) Q2 results are likely to reflect gains from the innovative product line and efforts to reduce costs amid inflationary pressures and a demand shift.
Medifast (MED) Queued for Q2 Earnings: Things to Consider
by Zacks Equity Research
Medifast's (MED) second-quarter 2023 performance will likely reflect challenges related to customer acquisition and higher cost inflation.
Beyond Meat (BYND) Q2 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Amid macroeconomic concerns, Beyond Meat (BYND) introduces innovations, expanded distribution, and made progress in its operations. The impacts of these are likely to get reflected in its Q2 results.
What Must You Know Ahead of Tyson Foods' (TSN) Q3 Earnings?
by Zacks Equity Research
Tyson Foods' (TSN) third-quarter results are likely to reflect gains from the rising demand for protein amid escalated input costs.
Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2023 results reflect sales growth in the North America and International regions due to solid pricing. Management reaffirms the adjusted EBITDA and adjusted EPS guidance for 2023.
Nu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings Beat
by Zacks Equity Research
Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.
5 Top Stocks Likely to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Coty (COTY), BJ's Restaurants (BJRI), DexCom (DXCM), Livent (LTHM) and D.R. Horton (DHI).
E.l.f. Beauty (ELF) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 89.66% and 16.99%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Impact TreeHouse Foods' (THS) Q2 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results are likely to reflect resilient growth through efficient pricing and cost-control measures despite supply challenges.
What's on the Cards for Monster Beverage (MNST) in Q2 Earnings?
by Zacks Equity Research
Monster Beverage's (MNST) Q2 results are expected to reflect gains from continued strength in the energy drinks category and robust product innovation plans.
Is a Beat in Store for Kellogg (K) in Q2 Earnings Release?
by Zacks Equity Research
Kellogg's (K) second-quarter results are likely to reflect gains from revenue growth management efforts amid elevated costs.
Kraft Heinz (KHC) Queued for Q2 Earnings: Things to Consider
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2023 earnings is likely to reflect gains from robust pricing actions and strength in the operating model.
Keurig Dr Pepper (KDP) Q2 Earnings Top Estimates, Sales View Up
by Zacks Equity Research
Keurig Dr Pepper's (KDP) second-quarter 2023 results reflect increases in sales and earnings, driven by continued brand strength and significant pricing.
Altria Group (MO) Queues for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Altria Group's (MO) second-quarter results are likely to reflect gains from pricing and strength in Oral Tobacco Products, though soft cigarette volumes have been a concern.
Coty (COTY) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Coty (COTY) closed at $12.41, marking a -1.12% move from the previous day.
What to Note Ahead of Service Corp's (SCI) Q2 Earnings?
by Zacks Equity Research
Service Corp's (SCI) second-quarter 2023 performance is likely to have been affected by inflationary pressure. Strength in the preened cemetery sales has been an upside.
Factors to Note Ahead of Sysco Corporation's (SYY) Q4 Earnings
by Zacks Equity Research
Sysco's (SYY) fiscal fourth-quarter earnings is likely to reflect gains from the Recipe for Growth initiative. However, rising cost inflation might have been a hurdle.
Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.
Why Coty (COTY) Could Beat Earnings Estimates Again
by Zacks Equity Research
Coty (COTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Procter & Gamble (PG) is Poised for Q4 Earnings Beat
by Zacks Equity Research
Procter & Gamble's (PG) unwavering commitment to leverage its brand strength and adopt effective strategies has been bolstering its organic sales and market position.
Colgate (CL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) second-quarter 2023 sales are likely to have benefited from strong demand for its products, innovation, brand strength and a focus on premiumization. Rising costs and expenses might have hurt its margins.
Is Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Coty (COTY) have performed compared to their sector so far this year.
Mondelez (MDLZ) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Mondelez's (MDLZ) second-quarter 2023 performance is likely to gain from effective pricing actions and prudent buyouts. Strength in the company's snacking category is an upside.
Is a Beat in Store for Church & Dwight (CHD) in Q2 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter results are likely to reflect gains from pricing, innovation and demand amid elevated costs.